{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:07:33Z","timestamp":1789744053996,"version":"4.0.1"},"reference-count":148,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["31-135559\/1"],"award-info":[{"award-number":["31-135559\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u201cStiftung f\u00fcr Kardiovaskul\u00e4re Forschung Basel\u201d"},{"DOI":"10.13039\/501100004784","name":"Novartis Foundation for Medical-Biological Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.bbamcr.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T18:00:50Z","timestamp":1452276050000},"page":"1894-1903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"PB","title":["mTOR, cardiomyocytes and inflammation in cardiac hypertrophy"],"prefix":"10.1016","volume":"1863","author":[{"given":"Lifen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2016.01.003_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ceb.2014.12.001","article-title":"MTOR signaling in cellular and organismal energetics","volume":"33","author":"Albert","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"Ma","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1042\/BST20110682","article-title":"Roles of the mammalian target of rapamycin, mTOR, in controlling ribosome biogenesis and protein synthesis","volume":"40","author":"Iadevaia","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0030","doi-asserted-by":"crossref","first-page":"C712","DOI":"10.1152\/ajpcell.00499.2006","article-title":"S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover","volume":"293","author":"Mieulet","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0035","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/onc.2012.606","article-title":"Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program","volume":"33","author":"Chauvin","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Hsieh","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11083","article-title":"A unifying model for mTORC1-mediated regulation of mRNA translation","volume":"485","author":"Thoreen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0050","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1128\/MCB.24.14.6231-6240.2004","article-title":"Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy","volume":"24","author":"McMullen","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0055","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/emboj\/19.11.2537","article-title":"The conserved phosphoinositide 3-kinase pathway determines heart size in mice","volume":"19","author":"Shioi","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0060","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.bbagrm.2014.08.015","article-title":"The race to decipher the top secrets of TOP mRNAs","volume":"1849","author":"Meyuhas","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0065","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1073\/pnas.1201689109","article-title":"Distinct perturbation of the translatome by the antidiabetic drug metformin","volume":"109","author":"Larsson","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0070","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","article-title":"mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation","volume":"18","author":"Morita","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0075","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1172\/JCI77361","article-title":"Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity","volume":"125","author":"Tsai","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0080","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cmet.2012.04.007","article-title":"TOR signaling and rapamycin influence longevity by regulating SKN-1\/Nrf and DAF-16\/FoxO","volume":"15","author":"Robida-Stubbs","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2009.07.034","article-title":"4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila","volume":"139","author":"Zid","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cmet.2011.05.010","article-title":"Life span extension via eIF4G inhibition is mediated by posttranscriptional remodeling of stress response gene expression in C. elegans","volume":"14","author":"Rogers","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gde.2012.12.005","article-title":"mTOR in aging, metabolism, and cancer","volume":"23","author":"Cornu","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0100","article-title":"Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy","author":"Shende","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/cr.2013.166","article-title":"Autophagy regulation by nutrient signaling","volume":"24","author":"Russell","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0110","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/CIRCRESAHA.114.303788","article-title":"Molecular mechanisms of autophagy in the cardiovascular system","volume":"116","author":"Gatica","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0115","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCRESAHA.116.303787","article-title":"Untangling autophagy measurements: all fluxed up","volume":"116","author":"Gottlieb","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0120","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/bph.12477","article-title":"Autophagy and mitophagy in the myocardium: therapeutic potential and concerns","volume":"171","author":"Jimenez","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0125","article-title":"Role of autophagy in metabolic syndrome-associated heart disease","author":"Ren","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/FJC.0b013e3182646cb1","article-title":"Cardiac autophagy: good with the bad","volume":"60","author":"Rifki","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0135","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.116.303790","article-title":"Molecular mechanisms of mitochondrial autophagy\/mitophagy in the heart","volume":"116","author":"Saito","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0140","article-title":"Cardiomyocyte autophagy: metabolic profit and loss","author":"Wang","year":"2012","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0145","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nature13492","article-title":"Coordinated regulation of protein synthesis and degradation by mTORC1","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0150","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1177\/153537020623100705","article-title":"Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin\u2013proteasome system and onto human diseases and drug targeting","volume":"231","author":"Ciechanover","year":"2006","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0155","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/01.RES.0000252342.61447.a2","article-title":"Heart failure and protein quality control","volume":"99","author":"Wang","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/HCO.0b013e32834598fe","article-title":"The ubiquitin\u2013proteasome system in cardiomyopathies","volume":"26","author":"Schlossarek","year":"2011","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0165","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.1074\/jbc.R110.170571","article-title":"Tearin' up my heart: proteolysis in the cardiac sarcomere","volume":"286","author":"Portbury","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2013.11.008","article-title":"The role of ubiquitin ligases in cardiac disease","volume":"71","author":"Willis","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cmet.2015.01.016","article-title":"Protein quality control and metabolism: bidirectional control in the heart","volume":"21","author":"Wang","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0180","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.yjmcc.2011.10.023","article-title":"Back to your heart: ubiquitin proteasome system-regulated signal transduction","volume":"52","author":"Portbury","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0185","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/B978-0-12-397863-9.00009-2","article-title":"The ubiquitin\u2013proteasome system and cardiovascular disease","volume":"109","author":"Powell","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0190","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/acel.12203","article-title":"Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart","volume":"13","author":"Dai","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0195","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/emboj.2008.119","article-title":"Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling","volume":"27","author":"Ikenoue","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0200","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/emboj.2008.120","article-title":"The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C","volume":"27","author":"Facchinetti","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"MTOR kinase structure, mechanism and regulation","volume":"497","author":"Yang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0210","article-title":"Architecture of human mTOR complex 1","author":"Aylett","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0215","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4161\/auto.5.5.8504","article-title":"Rapamycin inhibits mTORC1, but not completely","volume":"5","author":"Thoreen","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0220","doi-asserted-by":"crossref","first-page":"1236566","DOI":"10.1126\/science.1236566","article-title":"mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin","volume":"341","author":"Kang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm3757","article-title":"Making new contacts: the mTOR network in metabolism and signalling crosstalk","volume":"15","author":"Shimobayashi","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0230","doi-asserted-by":"crossref","first-page":"H1696","DOI":"10.1152\/ajpheart.00545.2010","article-title":"Rapamycin treatment augments both protein ubiquitination and Akt activation in pressure-overloaded rat myocardium","volume":"300","author":"Harston","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0235","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yjmcc.2015.07.027","article-title":"The mammalian target of rapamycin modulates the immunoproteasome system in the heart","volume":"86","author":"Zhang","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2015.09.014","article-title":"Links between mTOR and the immunoproteasome: therapeutic targets for cardiac hypertrophy?","author":"Ackermann","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0245","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0250","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0255","doi-asserted-by":"crossref","first-page":"H1712","DOI":"10.1152\/ajpheart.00124.2004","article-title":"NF-kappaB activation is required for the development of cardiac hypertrophy in vivo","volume":"287","author":"Li","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0260","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.freeradbiomed.2005.08.002","article-title":"Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo","volume":"39","author":"Ha","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0265","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbrc.2004.12.002","article-title":"CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy","volume":"327","author":"Kashiwase","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0270","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2004.11.153","article-title":"Reduced cGMP signaling activates NF-kappaB in hypertrophied hearts of mice lacking natriuretic peptide receptor-a","volume":"327","author":"Vellaichamy","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0275","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0280","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI7362","article-title":"Mechanical strain activates BNP gene transcription through a p38\/NF-kappaB-dependent mechanism","volume":"104","author":"Liang","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0285","doi-asserted-by":"crossref","first-page":"G669","DOI":"10.1152\/ajpgi.2001.280.4.G669","article-title":"Activation of NF-kappaB by hepatitis B virus X protein through an IkappaB kinase-independent mechanism","volume":"280","author":"Purcell","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0290","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.CIR.0000085362.40608.DD","article-title":"Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy?","volume":"108","author":"Purcell","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0295","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/hc0402.102863","article-title":"Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy","volume":"105","author":"Hirotani","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0300","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","article-title":"Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo","volume":"111","author":"Freund","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0305","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/cvr\/cvp237","article-title":"NF-kappaB activation is required for adaptive cardiac hypertrophy","volume":"84","author":"Zelarayan","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd1279","article-title":"The IKK NF-kappa B system: a treasure trove for drug development","volume":"3","author":"Karin","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0315","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/cvr\/cvs078","article-title":"Receptor activator of nuclear factor-kappaB ligand is a novel inducer of myocardial inflammation","volume":"94","author":"Ock","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0320","doi-asserted-by":"crossref","first-page":"868753","DOI":"10.1155\/2014\/868753","article-title":"Rapamycin attenuated cardiac hypertrophy induced by isoproterenol and maintained energy homeostasis via inhibiting NF-kappaB activation","volume":"2014","author":"Chen","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0325","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCRESAHA.117.305349","article-title":"Cardiac nonmyocytes in the hub of cardiac hypertrophy","volume":"117","author":"Kamo","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0330","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCRESAHA.109.207456","article-title":"Intramyocardial fibroblast myocyte communication","volume":"106","author":"Kakkar","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0335","article-title":"The cardiomyocyte as a source of cytokines in cardiac injury","volume":"2011","author":"Aoyagi","year":"2012","journal-title":"J. Cell Sci. Ther."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0340","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00418-008-0541-5","article-title":"Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload","volume":"131","author":"Xia","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112710","article-title":"Ly6C(low) and not Ly6C(high) macrophages accumulate first in the heart in a model of murine pressure-overload","volume":"9","author":"Weisheit","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0350","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/cvr\/cvu030","article-title":"Myocyte signalling in leucocyte recruitment to the heart","volume":"102","author":"Ghigo","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0355","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCHEARTFAILURE.115.002225","article-title":"Left ventricular T-cell recruitment contributes to the pathogenesis of heart failure, Circulation","volume":"8","author":"Nevers","year":"2015","journal-title":"Heart Fail."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0360","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.20131125","article-title":"Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2","volume":"211","author":"Wang","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0365","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/MCB.22.8.2799-2809.2002","article-title":"Akt\/protein kinase B promotes organ growth in transgenic mice","volume":"22","author":"Shioi","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081325","article-title":"Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade","volume":"8","author":"Bishu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0375","doi-asserted-by":"crossref","first-page":"13842","DOI":"10.1074\/jbc.M801510200","article-title":"Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function","volume":"283","author":"Shen","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0380","article-title":"Mechanistic target of rapamycin (mTOR) is essential for murine embryonic heart development and growth","volume":"8","author":"Zhu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0385","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI43008","article-title":"MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice","volume":"120","author":"Zhang","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0390","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.110.977066","article-title":"Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice","volume":"123","author":"Shende","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0395","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.ajpath.2013.02.012","article-title":"Genetic and pharmacological inhibition of Rheb1-mTORC1 signaling exerts cardioprotection against adverse cardiac remodeling in mice","volume":"182","author":"Wu","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0400","doi-asserted-by":"crossref","first-page":"12661","DOI":"10.1073\/pnas.1301455110","article-title":"Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1","volume":"110","author":"Volkers","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0405","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1","volume":"11","author":"Guertin","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0410","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.devcel.2006.08.013","article-title":"Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability","volume":"11","author":"Shiota","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0415","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1101\/gad.1461206","article-title":"Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity","volume":"20","author":"Yang","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0420","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12256","article-title":"Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan","author":"Lamming","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0425","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.113.003638","article-title":"Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage","volume":"128","author":"Volkers","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0430","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/CIRCRESAHA.114.303562","article-title":"Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signaling","volume":"114","author":"Yano","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0435","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.celrep.2015.03.010","article-title":"mTORC2 regulates cardiac response to stress by inhibiting MST1","volume":"11","author":"Sciarretta","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0440","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/01.RES.77.6.1040","article-title":"Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy","volume":"77","author":"Sadoshima","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0445","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/01.RES.81.2.176","article-title":"Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase","volume":"81","author":"Boluyt","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0450","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.RES.0000041029.97988.E9","article-title":"Ras\/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes","volume":"91","author":"Wang","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0455","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1006\/jmcc.1998.0768","article-title":"Activation of p70(S6) kinase by beta-adrenoceptor agonists on adult cardiomyocytes","volume":"30","author":"Simm","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0460","doi-asserted-by":"crossref","first-page":"32670","DOI":"10.1074\/jbc.M102776200","article-title":"Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2 in cardiomyocytes","volume":"276","author":"Wang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0465","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1042\/BJ20041888","article-title":"Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)","volume":"388","author":"Rolfe","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0470","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/bj20030454","article-title":"Ca(2+)-independent protein kinase C activity is required for alpha1-adrenergic-receptor-mediated regulation of ribosomal protein S6 kinases in adult cardiomyocytes","volume":"373","author":"Wang","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0475","doi-asserted-by":"crossref","first-page":"23065","DOI":"10.1074\/jbc.M200328200","article-title":"c-Raf\/MEK\/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells","volume":"277","author":"Iijima","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0480","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.yjmcc.2007.09.015","article-title":"Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells","volume":"43","author":"Moschella","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0485","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1101\/gad.1492806","article-title":"Regulation of cardiac growth and coronary angiogenesis by the Akt\/PKB signaling pathway","volume":"20","author":"Shiojima","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0490","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000057979.36322.88","article-title":"Rapamycin attenuates load-induced cardiac hypertrophy in mice","volume":"107","author":"Shioi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0495","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/01.CIR.0000130641.08705.45","article-title":"Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload","volume":"109","author":"McMullen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0500","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.jacc.2004.09.044","article-title":"Impact of beta-myosin heavy chain expression on cardiac function during stress","volume":"44","author":"Krenz","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0505","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.RES.88.4.373","article-title":"Adenoviral-mediated serca gene transfer into cardiac myocytes: how much is too much?","volume":"88","author":"Periasamy","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0510","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1006\/jmcc.2001.1366","article-title":"SERCA pump level is a critical determinant of Ca(2+)homeostasis and cardiac contractility","volume":"33","author":"Periasamy","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0515","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1096\/fj.02-0474fje","article-title":"Cardiac-specific overexpression of a high Ca2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy","volume":"17","author":"Nakayama","year":"2003","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0520","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cvr\/cvq308","article-title":"Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart","volume":"89","author":"Creemers","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0525","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/01.hjh.0000239304.01496.83","article-title":"Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis","volume":"24","author":"Gao","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0530","doi-asserted-by":"crossref","first-page":"H75","DOI":"10.1152\/ajpheart.00241.2012","article-title":"Cardiac mTOR protects the heart against ischemia\u2013reperfusion injury","volume":"303","author":"Aoyagi","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0535","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ki.2008.690","article-title":"Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure","volume":"75","author":"Siedlecki","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0540","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1172\/JCI24682","article-title":"Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure","volume":"115","author":"Shiojima","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0545","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yjmcc.2013.10.019","article-title":"Myofibroblasts: trust your heart and let fate decide","volume":"70","author":"Davis","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0550","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yjmcc.2014.01.008","article-title":"Myocardial fibroblast\u2013matrix interactions and potential therapeutic targets","volume":"70","author":"Goldsmith","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0555","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1242\/jcs.162891","article-title":"Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease","volume":"128","author":"Schroer","year":"2015","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0560","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCRESAHA.114.302533","article-title":"Myocardial extracellular matrix: an ever-changing and diverse entity","volume":"114","author":"Rienks","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0565","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0008-6363(03)00534-0","article-title":"Induction of protein synthesis in cardiac fibroblasts by cardiotrophin-1: integration of multiple signaling pathways","volume":"60","author":"Freed","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0570","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cardiores.2005.05.025","article-title":"Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload","volume":"68","author":"Ha","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0575","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCHEARTFAILURE.112.000061","article-title":"Bidirectional regulation of nuclear factor-kB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes, Circulation","volume":"6","author":"R","year":"2013","journal-title":"Heart Fail."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0580","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NFkappaB signaling pathways","volume":"131","author":"Zhao","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0585","doi-asserted-by":"crossref","first-page":"C1256","DOI":"10.1152\/ajpcell.00338.2010","article-title":"MTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy","volume":"299","author":"Song","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0590","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yjmcc.2008.09.002","article-title":"With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure","volume":"46","author":"Molkentin","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0595","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/HYPERTENSIONAHA.109.138818","article-title":"Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats","volume":"54","author":"Soesanto","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0600","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","article-title":"Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation","volume":"121","author":"Marin","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0605","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/en.2007-0099","article-title":"Rapamycin prevents thyroid hormone-induced cardiac hypertrophy","volume":"148","author":"Kuzman","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0610","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2009.08.031","article-title":"Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction","volume":"54","author":"Buss","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0615","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/HYPERTENSIONAHA.113.02526","article-title":"Inhibition of mammalian target of rapamycin with rapamycin reverses hypertrophic cardiomyopathy in mice with cardiomyocyte-specific knockout of PTEN","volume":"63","author":"Xu","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0620","doi-asserted-by":"crossref","first-page":"H231","DOI":"10.1152\/ajpheart.00665.2011","article-title":"The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling","volume":"302","author":"Schramm","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0625","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.yjmcc.2011.10.015","article-title":"Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways","volume":"52","author":"Clemente","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0630","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.yjmcc.2011.06.021","article-title":"Focal adhesion kinase\u2014the basis of local hypertrophic signaling domains","volume":"52","author":"Franchini","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0635","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s40064-015-1230-1","article-title":"Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation","volume":"4","author":"Drolet","year":"2015","journal-title":"SpringerPlus"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0640","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/acel.12109","article-title":"Late-life rapamycin treatment reverses age-related heart dysfunction","volume":"12","author":"Flynn","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0645","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0650","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity","volume":"335","author":"Lamming","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0655","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins","volume":"166","author":"Harrington","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0660","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","article-title":"Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity","volume":"431","author":"Um","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0665","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","article-title":"Inappropriate activation of the TSC\/rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies","volume":"14","author":"Shah","year":"2004","journal-title":"Curr. Biol.: CB"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0670","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.1199484","article-title":"Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling","volume":"332","author":"Yu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0675","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.1199498","article-title":"The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling","volume":"332","author":"Hsu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0680","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI43008","article-title":"MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice","volume":"120","author":"Zhang","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0685","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/acel.12313","article-title":"Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins","volume":"14","author":"Schreiber","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0690","article-title":"Cellular interplay between cardiomyocytes and nonmyocytes in cardiac remodeling","volume":"2011","author":"Takeda","year":"2011","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0695","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF02938356","article-title":"Role of inflammation in the progression of heart failure","volume":"9","author":"Yndestad","year":"2007","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0700","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cca.2014.09.001","article-title":"Inflammatory cytokines as biomarkers in heart failure","volume":"443","author":"Ueland","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0705","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11897-014-0185-9","article-title":"Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure","volume":"11","author":"Askevold","year":"2014","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0710","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00395-011-0222-8","article-title":"Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy","volume":"106","author":"Hua","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0715","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1172\/JCI67674","article-title":"Rapamycin extends murine lifespan but has limited effects on aging","volume":"123","author":"Neff","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-430-8_1","article-title":"Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life","volume":"821","author":"Weichhart","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0725","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri3901","article-title":"Regulation of innate immune cell function by mTOR","volume":"15","author":"Weichhart","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0730","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.it.2009.02.002","article-title":"The multiple facets of mTOR in immunity","volume":"30","author":"Weichhart","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0735","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3390\/nu5062231","article-title":"The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses","volume":"5","author":"Soliman","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.bbamcr.2016.01.003_bb0740","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.it.2014.10.006","article-title":"Intersection of mTOR and STAT signaling in immunity","volume":"36","author":"Saleiro","year":"2015","journal-title":"Trends Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488916000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488916000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T07:25:00Z","timestamp":1717226700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488916000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":148,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0167488916000069"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2016.01.003","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mTOR, cardiomyocytes and inflammation in cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}